Physician profile
Karla Bailey
NPI 1700433604
$334.13
in general payments reported to CMS, 2019-2025
10 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $37.59 · 2024: $91.57 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $54.88 | 2025 | |
| Novo Nordisk INC | $49.74 | 2023-2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $42.25 | 2024-2025 | |
| Pfizer INC. | $38.04 | 2024 | |
| Lilly USA, LLC | $37.04 | 2025 | Mounjaro, Zepbound |
| Organon LLC | $35.13 | 2024-2025 | Nexplanon |
| Viiv Healthcare Company | $20.84 | 2023 | Rukobia |
| Hologic Sales and Service, LLC | $20.15 | 2025 | Aptima |
| Dexcom, INC. | $19.25 | 2024 | Dexcom G6 Transmitter |
| Gilead Sciences, INC. | $16.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.